Type
. Leprosy and infection with the human immunodeficiency virus in Uganda; a case-control study. International journal of leprosy & other Mycobactial diseases [Internet]. 1994;62(4):521-6. Available from: http://ila.ilsl.br/pdfs/v62n4a03.pdf
Type
. Leprosy care. The impact of multiple drug therapy. Africa health. 1994;16(4):21-4.
Type
. Protective efficacy of BCG against leprosy in Northern Malawi. Lancet [Internet]. 1986;2(8505):499-502. Available from: http://www.med.mcgill.ca/epidemiology/Hanley/bios601/CaseControlStudies/FineEtAlBCGleprosy.pdf
Type
B.C.G.: sibling rivalry. Lancet. 1982;1(8265):206.
Type
Susceptibility of the host--role of non-genetic factors. Leprosy in India. 1982;54(4):721-82.
Type
. [BCG and leprosy]. Bull Soc Pathol Exot Filiales. 1983;76(3):236-42.
Type
. An overview on the leprosy vaccine. Indian journal of leprosy. 1984;56(2):301-6.
Type
. Giant reactions to tuberculin in lepromatous leprosy patients. International journal of leprosy & other Mycobactial diseases [Internet]. 1985;53(4):546-53. Available from: http://ila.ilsl.br/pdfs/v53n4a05.pdf
Type
. BCG vaccination in leprosy. Devopments in biological standardization. 1986;58 ( Pt A):287-92.
Type
. Human immunodeficiency virus and leprosy--type 1 reactions, nerve damage and steroid therapy: 'a case report'. Leprosy review [Internet]. 1993;64(3):267-9. Available from: http://leprev.ilsl.br/pdfs/1993/v64n3/pdf/v64n3a11.pdf
Pagination
- Previous page
- Page 166
- Next page